摘要
目的:促进基本药物目录实现"由虚转实"。方法:通过对《国家基本药物目录》遴选相关问题的探讨,对现存问题进行分析。结果与结论:基本药物遴选工作中,在"安全"与"有效"的协调、价格、中药选取上都存在着若干问题,"临床首选"也未能完全体现。在遴选程序制定、药品单独论证上也存在或大或小的问题,评价工作的可信度不高。总之,基本药物目录遴选和制定还要不断的调整与完善,保障公众基本用药需求。
OBJECTIVE：To promote essential drug list into practice.METHODS：Relevant problems on the selection of National Essential Drug List were explored and analyzed.RESULTS CONCLUSION：There are some problems on coordination of safety and effectiveness of drugs,price and the selection of traditional Chinese medicine.The advantage of first choice of essential drugs is not reflected completely.Large or small problems exist in selection process and individual drug verification.There was low credibility of drug evaluation.On the whole,the selection and formulation of essential drug list should be adjusted and improved continuously to guarantee the requirement of public medication.
出处
《中国药房》
CAS
CSCD
北大核心
2010年第24期2211-2213,共3页
China Pharmacy
关键词
基本药物目录
遴选
原则
机制
Essential drug list
Selection
Principal
Mechanism
